Compare INAB & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INAB | ALAR |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 10.7M |
| IPO Year | 2020 | 2018 |
| Metric | INAB | ALAR |
|---|---|---|
| Price | $0.75 | $0.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $7.00 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 69.2K | 20.9K |
| Earning Date | 11-05-2026 | 12-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $24.89 |
| Revenue Next Year | N/A | $26.13 |
| P/E Ratio | ★ N/A | $44.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $1.00 |
| 52 Week High | $2.73 | $12.00 |
| Indicator | INAB | ALAR |
|---|---|---|
| Relative Strength Index (RSI) | 32.88 | 26.94 |
| Support Level | N/A | N/A |
| Resistance Level | $1.50 | $1.59 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 9.62 | 2.45 |
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.